Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma

Abstract

These data suggest that piroxicam sensitizes mesothelioma cells to CDDP-induced cytotoxicity by modulating the expression of several target genes. Therefore, piroxicam in combination with CDDP might potentially be useful in the treatment of patients with mesothelioma.